Curcumin Analogs Induce Apoptosis and G2/M Arrest In 4T1 Murine Triple-Negative Breast Cancer Cells

Retno Murwanti, Azmi Rahmadani, Ritmaleni Ritmaleni, Adam Hermawan, Bambang Sulistiyo Ari Sudarmanto


Chemotherapy is the first-line treatment for triple-negative breast cancer (TNBC), yet toxicity and resistance effects have been the current problems. Curcumin,a natural compound, has been reported to exert anti-proliferative effects on various cancer cells, including breast carcinoma cells. However, the β-diketone moiety influences the stability of curcumin. Curcumin analogs, pentagamavunon-0 (PGV-0), and pentagamavunon-1 (PGV-1) were synthesized to improve the stability and activity of curcumin by modified the β-diketone moiety into mono-ketone pentanone. In this study, we evaluated the cytotoxicity, inhibition of cell cycle progression, and induction of apoptosis of curcumin and its analogs (PGV-0 and PGV-1) in murine triple-negative breast cancer 4T1 cell line. The cytotoxic evaluation was done by MTT assay, while apoptosis induction and cell cycle evaluation was performed by annexin V staining and detected by flow cytometry. Curcumin and its analogs, PGV-0, and  PGV-1, significantly inhibit the viability of 4T1 breast cancer cells with an IC50 value of 34.34µg/mL, 13.76µg/mL and 38.21μg/mL, respectively. Apoptosis analysis with a dose of 10µg/mL and 15µg/mL in 4T1 breast cancer cells showed that curcumin and its analogs effectively induce apoptotic in a dose-dependent manner. In cell cycle analysis using a dose of 15µg/mL, curcumin inhibited the cell cycle progression in the S phase, whereas PGV-0 and PGV-1 inhibited the cell cycle in the G2/M phase. It could be concluded that curcumin analogs, PGV-0 and PGV-1, have higher potential to be developed as anti-cancer agents by inducing cell cycle arrest and apoptosis in triple-negative breast cancer.


Apoptosis; Cell cycle arrest; PGV-0; PGV-1; TNBC

Full Text:



Adams, B.K., Cai, J., Armstrong, J., Herold, M., Lu, Y.J., Sun, A., Snyder, J.P., Liotta, D.C., Jones, D.P., Shoji, M., 2005. EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism: Anti-Cancer Drugs 16, 263–275.

Aggarwal, S., 2005. Curcumin (Diferuloylmethane) Downregulates Expression of Cell Proliferation, Antiapoptotic and Metastatic Gene Products Through Suppression of I B Kinase and AKT Activation. Molecular Pharmacology.

Almuradova, D.M., 2018. The Role of Chemotherapy in Triple Negative Breast Cancer 2, 5.

Atsumi, T., Murakami, Y., Shibuya, K., Tonosaki, K., Fujisawa, S., 2005. Induction of Cytotoxicity and Apoptosis and Inhibition of Cyclooxygenase-2 Gene Expression, by Curcumin and its Analog, α-Diisoeugenol. Anticancer Res 25, 4029–4036.

Bar-Sela, G., Epelbaum, R., Schaffer, M., 2010. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Curr. Med. Chem. 17, 190–197.

Bevan, P., Ryder, H., Shaw, I., 1995. Identifying small-molecule lead compounds: The screening approach to drug discovery. Trends in Biotechnology 13, 115–121.

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A., Jemal, A., 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 68, 394–424.

Chan, W.-H., Wu, H.-J., Hsuuw, Y.-D., 2005. Curcumin inhibits ROS formation and apoptosis in methylglyoxal-treated human hepatoma G2 cells. Ann. N. Y. Acad. Sci. 1042, 372–378.

Cheok, C.F., 2012. Protecting normal cells from the cytotoxicity of chemotherapy. Cell Cycle 11, 2227.

Foulkes, W.D., Smith, I.E., dan Reis-Filho, J.S., 2010. Triple-negative breast cancer. The New England Journal of Medicine, 363: 1938–1948.

Guo, Z., 2017. The modification of natural products for medical use. Acta Pharmaceutica Sinica B, Traditional Chinese medicine and natural products research 7, 119–136.

Ikawati, M., Septisetyani, E.P., 2018. Pentagamavunone-0 (PGV-0), a Curcumin Analog, Enhances Cytotoxicity of 5-Fluorouracil and Modulates Cell Cycle in WiDr Colon Cancer Cells. Indonesian Journal of Cancer Chemoprevention 9, 23–31.

Isakoff, S.J., 2010. Triple Negative Breast Cancer: Role of Specific Chemotherapy Agents. Cancer J 16, 53–61.

Khazir, J., Mir, B.A., Mir, S.A., Cowan, D., 2013. Natural products as lead compounds in drug discovery. Journal of Asian Natural Products Research 15, 764–788.

Khodjakov, A., Rieder, C.L., 2009. The nature of cell-cycle checkpoints: facts and fallacies. Journal of Biology 8, 88.

Kim, H., Choi, D.H., Park, W., Huh, S.J., Nam, S.J., Lee, J.E., Ahn, J.S., Im, Y.-H., 2013. Prognostic factors for survivals from first relapse in breast cancer patients: analysis of deceased patients. Radiat Oncol J 31, 222–227.

Kulchitsky, V.A., Potkin, V.I., Zubenko, Y.S., Chernov, A.N., Talabaev, M.V., Demidchik, Y.E., Petkevich, S.K., Kazbanov, V.V., Gurinovich, T.A., Roeva, M.O., Grigoriev, D.G., Kletskov, A.V., Kalunov, V.N., 2012. Cytotoxic effects of chemotherapeutic drugs and heterocyclic compounds at application on the cells of primary culture of neuroepithelium tumors. Med Chem 8, 22–32.

Lee, D.S., Lee, M.K., Kim, J.H., 2009. Curcumin Induces Cell Cycle Arrest and Apoptosis in Human Osteosarcoma (HOS) Cells. Anticancer Res 29, 5039–5044.

Mayol, L., Serri, C., Menale, C., Crispi, S., Piccolo, M.T., Mita, L., Giarra, S., Forte, M., Saija, A., Biondi, M., Mita, D.G., 2015. Curcumin loaded PLGA–poloxamer blend nanoparticles induce cell cycle arrest in mesothelioma cells. European Journal of Pharmaceutics and Biopharmaceutics 93, 37–45.

Meiyanto, E., 2011. PGV-0 and PGV-1 Increased Apoptosis Induction of Doxorubicin on MCF-7 Breast Cancer Cells. Pharmacon: Jurnal Farmasi Indonesia 12, 55-59–59.

Meiyanto, E., Agustina, D., Am, S., Da’i, M., 2018. PGV-0 Induces Apoptosis on T47D Breast Cancer Cell Line Through CASPASE-3 Activation 11.

Motterlini, R., Foresti, R., Bassi, R., Green, C.J., 2000. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radical Biology and Medicine 28, 1303–1312.

Sardjiman, S.S., Reksohadiprodjo, M.S., Hakim, L., van der Goot, H., Timmerman, H., 1997. 1,5-Diphenyl-1,4-pentadiene-3-ones and cyclic analogues as antioxidative agents. Synthesis and structure-activity relationship. European Journal of Medicinal Chemistry 32, 625–630.

Vyas, A., Dandawate, P., Padhye, S., Ahmad, A., Sarkar, F., 2013. Perspectives on New Synthetic Curcumin Analogs and their Potential Anticancer Properties. Curr Pharm Des 19, 2047–2069.

Xia, Y.-Q., Wei, X.-Y., Li, W.-L., Kanchana, K., Xu, C.-C., Chen, D.-H., Chou, P.-H., Jin, R., Wu, J.-Z., Liang, G., 2014. Curcumin Analogue A501 induces G2/M Arrest and Apoptosis in Non-small Cell Lung Cancer Cells. Asian Pacific Journal of Cancer Prevention 15, 6893–6898.

Xiao, Z., Morris-Natschke, S.L., Lee, K.-H., 2016. Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates. Med Res Rev 36, 32–91.

Zamrus, S.N.H., Akhtar, M.N., Yeap, S.K., Quah, C.K., Loh, W.-S., Alitheen, N.B., Zareen, S., Tajuddin, S.N., Hussin, Y., Shah, S.A.A., 2018. Design, synthesis and cytotoxic effects of curcuminoids on HeLa, K562, MCF-7 and MDA-MB-231 cancer cell lines. Chem Cent J 12.

Zhang, X., Chen, M., Zou, P., Kanchana, K., Weng, Q., Chen, W., Zhong, P., Ji, J., Zhou, H., He, L., Liang, G., 2015. Curcumin analog WZ35 induced cell death via ROS-dependent ER stress and G2/M cell cycle arrest in human prostate cancer cells. BMC Cancer 15, 866.

Zhu, Y., Bu, S., 2017. Curcumin Induces Autophagy, Apoptosis, and Cell Cycle Arrest in Human Pancreatic Cancer Cells. Evidence-Based Complementary and Alternative Medicine 2017, 1–13.



  • There are currently no refbacks.

Copyright (c) 2020 Indonesian Journal of Pharmacy

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Indonesian J Pharm indexed by:

analytics View My Stats